Guorong Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guorong Shi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Aiping Liu
National Engineering Research Center for Agrochemicals, Hunan Research Institute of Chemical Industry, Changsha, P. R. China
2 shared publications Jianming Li
National Engineering Research Center for Agrochemicals, Hunan Research Institute of Chemical Industry, Changsha, P. R. China
2 shared publicationsShaofei Guan
School of Chemistry and Materials Science, Hunan Agricultural University, Changsha, P. R. China
2 shared publicationsShufen Chen
National Engineering Research Center for Agrochemicals, Hunan Research Institute of Chemical Industry, Changsha, P. R. China
2 shared publicationsWeidong Liu
National Engineering Research Center for Agrochemicals, Hunan Research Institute of Chemical Industry, Changsha, P. R. China
2 shared publicationsYating Liu
Tobacco Research Institute, Hunan Agricultural University, Changsha 410128, China
2 shared publications
Latest Publications
- Open Access
- 11 July 2023
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 263, 115240
Efficient heterogeneous Fenton-like degradation of methylene blue using green synthesized yeast supported iron nanoparticles
- 11 July 2023
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 263, 115240
Open AccessEfficient heterogeneous Fenton-like degradation of methylene blue using green synthesized yeast supported iron nanoparticles
- 2 April 2023
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 32 (5) , 990-1000
Design, synthesis, and fungicidal activity of pyrimidinamine derivatives containing pyridin-2-yloxy moiety
- 2 April 2023
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 32 (5) , 990-1000
Design, synthesis, and fungicidal activity of pyrimidinamine derivatives containing pyridin-2-yloxy moiety
- 20 February 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (8) , 3742-3750
Discovery of HNPC-A9229: A Novel Pyridin-2-yloxy-Based Pyrimidin-4-amine Fungicide
To search for novel pesticides, the synthesis around commercialized insecticide tebufenpyrad accidentally led us to the discovery of the fungicidal lead compound, 3-ethyl-1-methyl-N-((2-phenylthiazol-4-yl)methyl)-1H-pyrazole-5-carboxamide (1a) and its pyrimidin-4-amine-based optimization derivative 5-chloro-2,6-dimethyl-N-(1-(2-(p-tolyl)thiazol-4-yl)ethyl)pyrimidin-4-amine (2a). Compound 2a not only demonstrates fungicidal activity superior to commercial fungicides such as diflumetorim but also exhibits the good features that come with pyrimidin-4-amines, such as unique modes of action and no cross-resistance to other pesticide classes. However, 2a is highly toxic to rats. Further optimization of 2a by introducing pyridin-2-yloxy substructure finally led to the discovery of 5b5-6 (HNPC-A9229) (5-chloro-N-(1-((3-chloropyridin-2-yl)oxy)propan-2-yl)-6-(difluoromethyl)-pyrimidin-4-amine). HNPC-A9229 exhibits excellent fungicidal activities with EC50 values of 0.16 mg/L against Puccinia sorghi and 1.14 mg/L against Erysiphe graminis, respectively. Not only that its fungicidal potency is significantly superior to or comparable to commercial fungicides including diflumetorim, tebuconazole, flusilazole, and isopyrazam, HNPC-A9229 possesses low toxicity to rats.
- 20 February 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (8) , 3742-3750
Discovery of HNPC-A9229: A Novel Pyridin-2-yloxy-Based Pyrimidin-4-amine Fungicide
To search for novel pesticides, the synthesis around commercialized insecticide tebufenpyrad accidentally led us to the discovery of the fungicidal lead compound, 3-ethyl-1-methyl-N-((2-phenylthiazol-4-yl)methyl)-1H-pyrazole-5-carboxamide (1a) and its pyrimidin-4-amine-based optimization derivative 5-chloro-2,6-dimethyl-N-(1-(2-(p-tolyl)thiazol-4-yl)ethyl)pyrimidin-4-amine (2a). Compound 2a not only demonstrates fungicidal activity superior to commercial fungicides such as diflumetorim but also exhibits the good features that come with pyrimidin-4-amines, such as unique modes of action and no cross-resistance to other pesticide classes. However, 2a is highly toxic to rats. Further optimization of 2a by introducing pyridin-2-yloxy substructure finally led to the discovery of 5b5-6 (HNPC-A9229) (5-chloro-N-(1-((3-chloropyridin-2-yl)oxy)propan-2-yl)-6-(difluoromethyl)-pyrimidin-4-amine). HNPC-A9229 exhibits excellent fungicidal activities with EC50 values of 0.16 mg/L against Puccinia sorghi and 1.14 mg/L against Erysiphe graminis, respectively. Not only that its fungicidal potency is significantly superior to or comparable to commercial fungicides including diflumetorim, tebuconazole, flusilazole, and isopyrazam, HNPC-A9229 possesses low toxicity to rats.
- 1 August 2017
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 335, 170-177
Rapid green synthesis of gold nanocatalyst for high-efficiency degradation of quinclorac
- 1 August 2017
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 335, 170-177
Rapid green synthesis of gold nanocatalyst for high-efficiency degradation of quinclorac
- 10 August 2016
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 45 (6) , 1207-1215
Chemical treatment and chitosan coating of yeast cells to improve the encapsulation and controlled release of bovine serum albumin
We investigate the encapsulation of bovine serum albumin (BSA) in chemical-treated and chitosan-coated yeast cells, Saccharomyces cerevisiae (S. cerevisiae), for the controlled release of BSA. The chemical treatment can sufficiently enlarge the small-sized cell-wall cavities and/or break the integrity for the entrance of BSA to the interior of yeast cells, and the additional chitosan coating can well prevent the rapid release of encapsulated BSA from the yeast-derived microcapsules. The sodium hydroxide pretreated S. cerevisiae gives a maximum encapsulation yield of (10.1 ± 0.2)% for BSA. An additional coating of S. cerevisiae with chitosan can reduce the initial burst release of BSA and extend the release period from 24 h in the chitosan-free case to 48 h in phosphate buffer at pH 7.4. The prepared microcapsules can well keep the shapes and sizes of yeast cells and thus show uniform sizes of 3.85 ± 0.81 μm. The encapsulated BSA well retains its pristine ultraviolet spectroscopic and chromatographic behaviors. The present microencapsulation protocol has the advantages of convenient and mild operation, high encapsulation efficiency, and organic solvent-free nature, which is of reference value for establishing high-performance controllable biomacromolecule-delivery systems.
- 10 August 2016
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 45 (6) , 1207-1215
Chemical treatment and chitosan coating of yeast cells to improve the encapsulation and controlled release of bovine serum albumin
We investigate the encapsulation of bovine serum albumin (BSA) in chemical-treated and chitosan-coated yeast cells, Saccharomyces cerevisiae (S. cerevisiae), for the controlled release of BSA. The chemical treatment can sufficiently enlarge the small-sized cell-wall cavities and/or break the integrity for the entrance of BSA to the interior of yeast cells, and the additional chitosan coating can well prevent the rapid release of encapsulated BSA from the yeast-derived microcapsules. The sodium hydroxide pretreated S. cerevisiae gives a maximum encapsulation yield of (10.1 ± 0.2)% for BSA. An additional coating of S. cerevisiae with chitosan can reduce the initial burst release of BSA and extend the release period from 24 h in the chitosan-free case to 48 h in phosphate buffer at pH 7.4. The prepared microcapsules can well keep the shapes and sizes of yeast cells and thus show uniform sizes of 3.85 ± 0.81 μm. The encapsulated BSA well retains its pristine ultraviolet spectroscopic and chromatographic behaviors. The present microencapsulation protocol has the advantages of convenient and mild operation, high encapsulation efficiency, and organic solvent-free nature, which is of reference value for establishing high-performance controllable biomacromolecule-delivery systems.